Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ayurvedic caution

This article was originally published in The Tan Sheet

Executive Summary

Traditional Ayurvedic products may contain harmful metals and usually are not reviewed by FDA prior to sale, the agency says in an Oct. 16 consumer health article. FDA cites a study in the August Journal of the American Medical Association that shows one-fifth of Ayurvedic remedies made in India and the U.S. and purchased online contain lead, mercury or arsenic that exceeds acceptable daily metal intake levels (1"The Tan Sheet" Sept. 1, 2008, p. 6). FDA has kept an import alert on certain Ayurvedic products since 2007, "but individual Internet purchases are harder to monitor," says Michael Levy, director of the Office of Compliance's Division of New Drugs and Labeling Compliance in the agency's Center for Drug Evaluation and Research, in the article

You may also be interested in...



Call For Testing Metal Levels In Supplements Gets Mixed Reviews

Industry stakeholders differ on whether researchers are justified in recommending setting daily limits for toxic metals in dietary supplements

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel